Manulife (Manufacturers Life Insurance)
PLRX icon

Manulife (Manufacturers Life Insurance)’s Pliant Therapeutics PLRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,223
Closed -$28.7K – 2983
2025
Q1 		$28.7K Sell
21,223
-53,603
-72% -$325K ﹤0.01% 2875
2024
Q4 		$985K Sell
74,826
-442
-0.6% -$6.04K ﹤0.01% 1916
2024
Q3 		$844K Sell
75,268
-8,215
-10% -$103K ﹤0.01% 2008
2024
Q2 		$897K Buy
83,483
+1,191
+1% +$15.4K ﹤0.01% 1916
2024
Q1 		$1.23M Buy
82,292
+7,417
+10% +$122K ﹤0.01% 1742
2023
Q4 		$1.36M Buy
74,875
+7,694
+11% +$117K ﹤0.01% 1653
2023
Q3 		$1.16M Sell
67,181
-681
-1% -$11.8K ﹤0.01% 1652
2023
Q2 		$1.23M Buy
67,862
+27,009
+66% +$639K ﹤0.01% 1561
2023
Q1 		$1.09M Buy
40,853
+12,210
+43% +$348K ﹤0.01% 1593
2022
Q4 		$537K Buy
28,643
+203
+0.7% +$4.24K ﹤0.01% 1941
2022
Q3 		$590K Buy
+28,440
New +$544K ﹤0.01% 1870
2022
Q2 		– Sell
-11,300
Closed -$79.2K – 3106
2022
Q1 		$79.2K Sell
11,300
-2,197
-16% -$22.4K ﹤0.01% 2993
2021
Q4 		$182 Buy
13,497
+563
+4% +$8.95K ﹤0.01% 2924
2021
Q3 		$218K Sell
12,934
-692
-5% -$14.7K ﹤0.01% 2923
2021
Q2 		$397K Buy
13,626
+277
+2% +$8.62K ﹤0.01% 2599
2021
Q1 		$525K Buy
+13,349
New +$434K ﹤0.01% 2243

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PLRX Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 21,223 shares — an estimated $28.7K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PLRX in Q1 2021 and held it in 16 quarters. The position peaked at $1.36M in Q4 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 21,223 Pliant Therapeutics shares in Q2 2025, an estimated $28.7K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Pliant Therapeutics in Q1 2021 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Pliant Therapeutics position peaked at $1.36M in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.